CYP2B6 and CYP2C19 as the major enzymes responsible for the metabolism of selegiline, a drug used in the treatment of Parkinson's disease, as revealed from experiments with recombinant enzymes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples